January 2014 - Page 2 of 2 - Knowledge Ecology International

Blogs and Press coverage of Pharma/Medicine device industry lobbying on South Africa patent reform (pharmagate)

Posted on January 23, 2014 by KEI Staff

Boseley, Sarah. 17 January 2014. “South African pharma firms accused of planning to delay patents law reform.” The Guardian. http://www.theguardian.com/world/2014/jan/17/south-african-pharma-accused-delay-patents-law-reform

De Wet, Phillip. 17 January 2014. “Motsoaledi: Big pharma’s ‘satanic’ plot is genocide.” Mail & Guardian. http://mg.co.za/article/2014-01-16-motsoaledi-big-pharmas-satanic-plot-is-genocide/

Continue Reading →

Bayer CEO Marijn Dekkers explains: Nexavar cancer drug is for “western patients who can afford it.”

Posted on January 23, 2014 by James Love

Bayer CEO Marijn Dekkers called the Nexavar compulsory license “essentially theft.”

[UPDATE: The latest blog and transcript of Bayer CEO Marijn Dekkers’ full quote on the Indian compulsory license of Nexavar at the December Financial Times event is now available.]

Continue Reading →

New leaked Merck missive reveals deep drug, medical device company opposition to South African patent reforms

Posted on January 20, 2014 by James Love

Continue Reading →

2014: KEI testimony on WIPO broadcasting treaty, to House Judiciary Subcommittee on Courts, Intellectual Property, and Internet

Posted on January 14, 2014 by James Love

Testimony of James Packard Love
Hearing on: The Scope of Copyright Protection
January 14, 2014
Subcommittee on Courts, Intellectual Property, and the Internet

My 10 page written statement is here: /wp-content/uploads/JamesLove_Testimony.pdf

My 5 minute oral statement follows:

James Packard Love, Opening statement

Hearing on: The Scope of Copyright Protection
January 14, 2014
Subcommittee on Courts, Intellectual Property, and the Internet

Continue Reading →

WIPO hosts Conference on Open Innovation: Collaborative Projects and the Future of Knowledge (22-23 January 2014)

Posted on January 10, 2014 by Thiru

The World Intellectual Property Organization (WIPO) will host a “Conference on Open Innovation: Collaborative Projects and the Future of Knowledge” on 22-23 January 2014 at its headquarters in Geneva, Switzerland.

The origins of this conference on open collaborative development models is predicated upon Recommendation 36 of the WIPO Development Agenda which states:

Continue Reading →

Fast track trade bill fails to correct asymmetric secrecy of trade negotiations

Posted on January 10, 2014 by James Love

Today Senators Bacus and Hatch introduced fast track legislation in the Senate. The words transparent or transparency appear 17 times in the 107 page bill, but only twice in connection with “Trade Institution Transparency.”

Continue Reading →

LESI to convene Global Technology Impact Forum (20-21 January 2014) at WIPO followed by dinner at the Mandarin Oriental

Posted on January 9, 2014 by Thiru

The Licensing Executives Society International, Inc. (LESI) is convening its annual Global Technology Impact Forum (GTIF) at the headquarters of the World Intellectual Property Organization (WIPO) from 20 to 21 January 2014 in Geneva, Switzerland. Although this international forum is hosted in Room A at WIPO headquarters, this event (at the time of publication of this blog) does not appear on the calendar of WIPO events for January 2014. Continue Reading →

AstraZeneca’s 20-F, section on Risk Factors, for fiscal year ended December 31, 2012

Posted on January 8, 2014 by KEI Staff

From AstraZeneca’s 20-F, section on Risk Factors, for fiscal year ended December 31, 2012. Number of words in Item 1A: 8621 Compulsory licensing of patents: 45 3D. Risk Factors The information (including tabular data) set forth or referenced under the… Continue Reading →

GlaxoSmithKline’s 20-F report, section on Risk Factors, for fiscal year ended December 31, 2012.

Posted on January 7, 2014 by KEI Staff

From GlaxoSmithKline’s 20-F report, section on Risk Factors, for fiscal year ended December 31, 2012. Number of words in Item 3D: 6304 Compulsory licensing of patents: 42 3.D Risk factors Principal risk factors and uncertainties There are risks and uncertainties… Continue Reading →

USPTO 2013 utility patent grants (notes on country of assignment, invention class, government rights in patents)

Posted on January 3, 2014 by James Love

In 2013, the USPTO issued 277,861 utility patents, a new record in terms of the numbers of patent grants, and an increase of 9.8 percent over 2012.*

Country of Assignment

Of the total, 126,574 (45.6 percent) were assigned to a US owner, a small increase in the percent held by US entities over 2012.

Continue Reading →

James K. Glassman. Merck said Glassman’s public relations firm was selected by PhRMA to lead a campaign to keep drug prices high in South Africa. The Health Minister in South Africa referred to the campaign proposal as a genocidal conspiracy of satanic magnitude.

Month: January 2014

Blogs and Press coverage of Pharma/Medicine device industry lobbying on South Africa patent reform (pharmagate)

Bayer CEO Marijn Dekkers explains: Nexavar cancer drug is for “western patients who can afford it.”

New leaked Merck missive reveals deep drug, medical device company opposition to South African patent reforms

2014: KEI testimony on WIPO broadcasting treaty, to House Judiciary Subcommittee on Courts, Intellectual Property, and Internet

WIPO hosts Conference on Open Innovation: Collaborative Projects and the Future of Knowledge (22-23 January 2014)

Fast track trade bill fails to correct asymmetric secrecy of trade negotiations

LESI to convene Global Technology Impact Forum (20-21 January 2014) at WIPO followed by dinner at the Mandarin Oriental

AstraZeneca’s 20-F, section on Risk Factors, for fiscal year ended December 31, 2012

GlaxoSmithKline’s 20-F report, section on Risk Factors, for fiscal year ended December 31, 2012.

USPTO 2013 utility patent grants (notes on country of assignment, invention class, government rights in patents)

Categories